Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8476)

From Wikibase.slis.ua.edu

Revision as of 23:50, 19 May 2020 by Admin (talk | contribs) (‎Created claim: Property:P146: Item:Q8491, #quickstatements; #temporary_batch_1589931845914)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Publication: "Targeting cancer stem cell pathways for cancer therapy" published as Signal Transduct Target Ther; 2020 ; 5 8; DOI: 10.1038/s41392-020-0110-5

Language	Label	Description	Also known as
English	Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)	Publication: "Targeting cancer stem cell pathways for cancer therapy" published as Signal Transduct Target Ther; 2020 ; 5 8; DOI: 10.1038/s41392-020-0110-5

Statements

0 references

Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5)

0 references

Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5)

0 references

Section or subsection level in publication

Table appearing in a publication

0 references

IMRaD(C) Section

0 references

Section 1: Introduction (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 2: The concept of CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3: Factors regulating CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5)

0 references

Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5)

0 references

Sitelinks

⧼wikibase-sitelinks-sliswiki⧽(1 entry)

sliswiki Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5)

Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q8476&oldid=195789"